Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladderP Allard, Y Fradet, B Têtu, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|March 27, 1999
Quebec prostate cancer mortality dropped in 1996F Meyer, L Moore, I Bairati, et al.
The Journal of Urology|March 21, 1998
Dietary fat and advanced prostate cancerI Bairati, F Meyer, Y Fradet, et al.
Seminars in Urologic Oncology|May 1, 1997
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983H W Herr, Y Fradet, F A Klein
Prostaglandins and Medicine|July 1, 1980
Enhanced urinary prostaglandin E2 in postobstructive diuresis in humansY Fradet, J Simard, J H Grose, et al.
Transplantation|January 1, 1981
Characterization of lymphocytotoxic antibodies in renal transplantationR Roy, J G Lachance, Y Fradet, et al.
Clinical Nephrology|August 1, 1982
Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodiesY Fradet, R Roy, J G Lachance, et al.
World Journal of Urology|December 7, 2007
Bladder cancer markers in patient management: the current perspectiveB J Schmitz-Dräger, Y Fradet, H B Grossman
Cancer Causes & Control : CCC|September 11, 1999
Dietary fat and prostate cancer survivalF Meyer, I Bairati, R Shadmani, et al.
The Journal of Urology|March 1, 1997
Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladderE Lee, H Schwaibold, Y Fradet, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladderP Allard, Y Fradet, B Têtu, et al.
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|March 27, 1999
Quebec prostate cancer mortality dropped in 1996F Meyer, L Moore, I Bairati, et al.
The Journal of Urology|March 21, 1998
Dietary fat and advanced prostate cancerI Bairati, F Meyer, Y Fradet, et al.
Seminars in Urologic Oncology|May 1, 1997
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983H W Herr, Y Fradet, F A Klein
Prostaglandins and Medicine|July 1, 1980
Enhanced urinary prostaglandin E2 in postobstructive diuresis in humansY Fradet, J Simard, J H Grose, et al.
Transplantation|January 1, 1981
Characterization of lymphocytotoxic antibodies in renal transplantationR Roy, J G Lachance, Y Fradet, et al.
Clinical Nephrology|August 1, 1982
Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodiesY Fradet, R Roy, J G Lachance, et al.
World Journal of Urology|December 7, 2007
Bladder cancer markers in patient management: the current perspectiveB J Schmitz-Dräger, Y Fradet, H B Grossman
Cancer Causes & Control : CCC|September 11, 1999
Dietary fat and prostate cancer survivalF Meyer, I Bairati, R Shadmani, et al.
The Journal of Urology|March 1, 1997
Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladderE Lee, H Schwaibold, Y Fradet, et al.
Pageof 11